Decrease and dysfunction of endothelial progenitor cells in umbilical cord blood with maternal pre-eclampsia

Journal of Obstetrics and Gynaecology Research

Volumn 33, Issue 4, 2007, Pages 465-474

  Xia, Liang ^a   Zhou, Xin P ^a   Zhu, Jun H ^a   Xie, Xu D ^a   Zhang, Hao ^a   Wang, Xing X ^a   Chen, Jun Z ^a,b   Jian, Sun ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NONE   (China)

Author keywords

Cytokine; Endothelial progenitor cells; Pre eclampsia; sFlt 1; Umbilical cord blood

Indexed keywords

CD133 ANTIGEN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FLUORESCENT DYE; LECTIN; VASCULOTROPIN RECEPTOR 2;

ADULT; ANGIOGENESIS; ARTICLE; CELL ACTIVITY; CELL DAMAGE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LABOR; LASER MICROSCOPY; MALE; PREECLAMPSIA; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; STEM CELL; UMBILICAL CORD BLOOD; UMBILICAL CORD BLOOD FLOW;

ADULT; CELL GROWTH PROCESSES; CELL MOVEMENT; CYTOKINES; ENDOTHELIAL CELLS; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; MALE; NEOVASCULARIZATION, PATHOLOGIC; PRE-ECLAMPSIA; PREGNANCY; STEM CELLS;

EID: 34547668304     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2007.00555.x     Document Type: Article

References (43)

1. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening. BMJ 2002 325 : 157 160.
2. Roberts JM, Lain KY. Recent insights into the pathogenesis of preeclmapsia. Placenta 2002 23 : 359 372.
3. Frusca T, Morassi L, Pecorelli S, Grigolato P, Gastaldi A. Histological features of uteroplacental vessels in normal and hypertensive patients in relation to birthweight. Br J Obstet Gynaecol 1989 96 : 835 839.
4. Gill M, Dias S, Hattori K et al. Vascular trauma induces rapid but transient mobilization of VEGFR2+AC133+ endothelial precursor cells. Circ Res 2001 88 : 167 174.
5. Rafii S. Circulating endothelial precursors: mystery, reality, and promise. J Clin Invest 2000 105 : 17 19.
6. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S. Endothelial progenitor cells: new hope for a broken heart. Circulation 2003 107 : 3093 3100.
7. Murohara T, Ikeda H, Duan J et al. Transplanted cord blood-derived endothelial progenitor cells augment postnatal neovascularization. J Clin Invest 2000 105 : 1527 1536.
8. Kocher AA, Schuster MD, Szabolcs MJ et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001 7 : 430 436.
9. Grant MB, May WS, Caballero S et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 2002 8 : 607 612.
10. Asahara T, Masuda H, Takahashi T et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999 85 : 221 228.
11. Nagaya N, Kangawa K, Kanda M et al. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Circulation 2003 108 : 889 895.
12. Vasa M, Fichtlscherer S, Aicher A et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001 89 : e1 e7.
13. Tepper OM, Galiano RD, Capla JM et al. Human endothelial progenitor cells from type diabetes exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002 26 : 2781 2786.
14. Sugawara J, Mitsui-Saito M, Hayashi C et al. Decrease and senescence of endothelial progenitor cells in patients with preeclampsia. J Clin Endocrinol Metab 2005 90 : 5329 5332.
15. Kendall RL, Wang G, Thomas KA. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 1996 226 : 324 328.
16. Maynard SE, Min JY, Merchan J et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003 111 : 649 658.
17. Krysiak O, Bretschneider A, Zhong E et al. Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF. Circ Res 2005 97 : 1253 1261.
18. Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 2004 95 : 884 891.
19. Vasa M, Fichtlscherer S, Aicher A et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001 89 : E1 E7.
20. Rehman J, Li J, Parvathaneni L et al. Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J Am Coll Cardiol 2004 43 : 2314 2318.
21. Vasa M, Fichtlscherer S, Adler K et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001 103 : r21 r26.
22. Yamaguchi J, Kusano KF, Masuo O e? al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003 107 : 1322 1328.
23. Chen JZ, Zhu JH, Wang XX et al. Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood. J Mol Cell Cardiol 2004 36 : 233 239.
24. Tepper OM, Galiano DR, Capla JM et al. Human endothelial progenitor cells from type 2 diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002 106 : 2781 2786.
25. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002 109 : 337 346.
26. Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998 40 : 102 111.
27. Jonsson Y, Ruber M, Matthiesen L et al. Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol 2006 70 : 83 91.
28. Lockwood CJ, Matta P, Krikun G et al. Regulation of monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha and interleukin-1beta in first trimester human decidual cells: implications for preeclampsia. Am J Pathol 2006 168 : 445 452.
29. Beausejour A, Bibeau K, Lavoie JC, St-Louis J, Brochu M. Placental oxidative stress in a rat model of preeclampsia. Placenta 2007 28 : 52 58.
30. Tsao PN, Wei SC, Su YN, Chou HC, Chen CY, Hsieh WS. Excess soluble fms-like tyrosine kinase 1 and low platelet counts in premature neonates of preeclamptic mothers. Pediatrics 2005 116 : 468 472.
31. Staff AC, Braekke K, Harsem NK, Lyberg T, Holthe MR. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2005 122 : 33 39.
32. Matsubara K, Abe E, Matsubara Y, Kameda K, Ito M. Circulating endothelial progenitor cells during normal pregnancy and pre-eclampsia. Am J Reprod Immunol 2006 56 : 79 85.
33. Takeshi N, Tomoyuki F, Maki K et al. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 2004 145 : 4838 4845.
34. Tsatsaris V, Goffin F, Munaut C et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab 2003 88 : 5555 5563.
35. Kupferminc MJ, Peaceman AM, Dollberg S, Socol ML. Tumor necrosis factor-alpha is decreased in the umbilical cord plasma of patients with severe preeclampsia. Am J Perinatol 1999 16 : 203 208.
36. Kim YH, Kim CH, Cho MK et al. Total peroxyl radical-trapping ability and anti-oxidant vitamins of the umbilical venous plasma and the placenta in pre-eclampsia. J Obstet Gynaecol Res 2006 32 : 32 41.
37. Matsubara K, Abe E, Matsubara Y, Kameda K, Ito M. Circulating endothelial progenitor cells during normal pregnancy and pre-eclampsia. Am J Reprod Immnnol 2006 56 : 79 85.
38. Akita T, Murohara T, Ikeda H et al. Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization. Lab Invest 2003 83 : 65 73.
39. Fadini GP, Schiavon M, Cantini M et al. Circulating progenitor cells are reduced in patients with severe lung disease. Stem Cells 2006 24 : 1806 1813.
40. Zhang P, Schmidt M, Cook L. Maternal vasculopathy and histologic diagnosis of reeclampsia: poor correlation of histologic changes and clinical manifestation. Am J Obstet Gynecol 2006 194 : 1050 1056.
41. Walford N, Htun K, Akhilesh M. Detection of atherosis in preeclamptic placentas: comparison of two gross sampling protocols. Pediatr Dev Pathol 2005 8 : 61 65.
42. Redman CW, Sargent IL. The pathogenesis of pre-eclampsia. Gynecol Obstet Fertil 2001 29 : 518 522.
43. Staff AC, Braekke K, Harsem NK, Lyberg T, Holthe MR. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2005 122 : 33 39.